Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
557.99
+14.15 (2.60%)
At close: Oct 21, 2025, 4:00 PM EDT
543.69
-14.30 (-2.56%)
Pre-market: Oct 22, 2025, 6:45 AM EDT
Thermo Fisher Stock Forecast
Stock Price Forecast
The 15 analysts that cover Thermo Fisher stock have a consensus rating of "Buy" and an average price target of $589.13, which forecasts a 5.58% increase in the stock price over the next year. The lowest target is $470 and the highest is $678.
Price Target: $589.13 (+5.58%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Thermo Fisher stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 5 | 4 | 3 | 3 | 3 |
| Buy | 8 | 8 | 9 | 10 | 11 | 10 |
| Hold | 4 | 4 | 4 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 17 | 17 | 17 | 17 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $600 → $650 | Buy | Maintains | $600 → $650 | +16.49% | Oct 9, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $525 → $590 | Buy | Maintains | $525 → $590 | +5.74% | Oct 7, 2025 |
| Barclays | Barclays | Buy Maintains $550 → $585 | Buy | Maintains | $550 → $585 | +4.84% | Oct 2, 2025 |
| Barclays | Barclays | Hold → Buy Upgrades $490 → $550 | Hold → Buy | Upgrades | $490 → $550 | -1.43% | Sep 11, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 19, 2025 |
Financial Forecast
Revenue This Year
44.43B
from 42.88B
Increased by 3.61%
Revenue Next Year
46.57B
from 44.43B
Increased by 4.83%
EPS This Year
22.73
from 16.53
Increased by 37.50%
EPS Next Year
24.63
from 22.73
Increased by 8.39%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 46.8B | 50.2B | |||
| Avg | 44.4B | 46.6B | |||
| Low | 42.9B | 44.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.1% | 12.9% | |||
| Avg | 3.6% | 4.8% | |||
| Low | -0.0% | -0.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.79 | 26.25 | |||
| Avg | 22.73 | 24.63 | |||
| Low | 21.81 | 23.44 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 43.9% | 15.5% | |||
| Avg | 37.5% | 8.4% | |||
| Low | 31.9% | 3.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.